116 related articles for article (PubMed ID: 14967764)
1. Spinocerebellar ataxia type 17: latest member of polyglutamine disease group highlights unanswered questions.
Tsuji S
Arch Neurol; 2004 Feb; 61(2):183-4. PubMed ID: 14967764
[No Abstract] [Full Text] [Related]
2. Case of spinocerebellar ataxia type 17 (SCA17) associated with only 41 repeats of the TATA-binding protein (TBP) gene.
Nanda A; Jackson SA; Schwankhaus JD; Metzer WS
Mov Disord; 2007 Feb; 22(3):436. PubMed ID: 17149738
[No Abstract] [Full Text] [Related]
3. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
[TBL] [Abstract][Full Text] [Related]
4. SCA17 homozygote showing Huntington's disease-like phenotype.
Toyoshima Y; Yamada M; Onodera O; Shimohata M; Inenaga C; Fujita N; Morita M; Tsuji S; Takahashi H
Ann Neurol; 2004 Feb; 55(2):281-6. PubMed ID: 14755733
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging.
Loy CT; Sweeney MG; Davis MB; Wills AJ; Sawle GV; Lees AJ; Tabrizi SJ
Mov Disord; 2005 Nov; 20(11):1521-3. PubMed ID: 16037935
[TBL] [Abstract][Full Text] [Related]
6. Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2.
Velázquez-Pérez L; Seifried C; Santos-Falcón N; Abele M; Ziemann U; Almaguer LE; Martínez-Góngora E; Sánchez-Cruz G; Canales N; Pérez-González R; Velázquez-Manresa M; Viebahn B; von Stuckrad-Barre S; Fetter M; Klockgether T; Auburger G
Ann Neurol; 2004 Sep; 56(3):444-7. PubMed ID: 15349876
[TBL] [Abstract][Full Text] [Related]
7. Extrapyramidal signs are a common feature of spinocerebellar ataxia type 17.
Lee WW; Kim SY; Kim JY; Kim HJ; Park SS; Jeon BS
Neurology; 2009 Nov; 73(20):1708-9. PubMed ID: 19917997
[No Abstract] [Full Text] [Related]
8. A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea.
Park H; Jeon BS; Shin JH; Park SH
Parkinsonism Relat Disord; 2016 Jan; 22():106-7. PubMed ID: 26613966
[No Abstract] [Full Text] [Related]
9. [Advance in research on spinocerebellar ataxia 17].
Zhang J; Gu W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):44-7. PubMed ID: 24510561
[TBL] [Abstract][Full Text] [Related]
10. SCA 17 phenotype with intermediate triplet repeat number.
Herrema H; Mikkelsen T; Robin A; LeWitt P; Sidiropoulos C
J Neurol Sci; 2014 Oct; 345(1-2):269-70. PubMed ID: 25091452
[No Abstract] [Full Text] [Related]
11. Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17).
Hübner J; Sprenger A; Klein C; Hagenah J; Rambold H; Zühlke C; Kömpf D; Rolfs A; Kimmig H; Helmchen C
Neurology; 2007 Sep; 69(11):1160-8. PubMed ID: 17846415
[TBL] [Abstract][Full Text] [Related]
12. Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future.
Margolis RL
Expert Rev Mol Diagn; 2003 Nov; 3(6):715-32. PubMed ID: 14628900
[TBL] [Abstract][Full Text] [Related]
13. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
Paulson HL
Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
[TBL] [Abstract][Full Text] [Related]
14. [Spinocerebellar ataxia type 8(SCA 8)].
Izumi Y; Maruyama H; Kawakami H
No To Shinkei; 2001 Jan; 53(1):34-40. PubMed ID: 11211728
[No Abstract] [Full Text] [Related]
15. Spinocerebellar ataxia type 17 in a patient from an Indian kindred.
Haubenberger D; Prayer D; Bauer P; Pirker W; Zimprich A; Auff E
J Neurol; 2006 Nov; 253(11):1513-5. PubMed ID: 16972120
[No Abstract] [Full Text] [Related]
16. Focal dystonia as a presenting sign of spinocerebellar ataxia 17.
Hagenah JM; Zühlke C; Hellenbroich Y; Heide W; Klein C
Mov Disord; 2004 Feb; 19(2):217-20. PubMed ID: 14978680
[TBL] [Abstract][Full Text] [Related]
17. Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
Matsuyama Z; Yanagisawa NK; Aoki Y; Black JL; Lennon VA; Mori Y; Imoto K; Inuzuka T
Neurobiol Dis; 2004 Nov; 17(2):198-204. PubMed ID: 15474358
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family.
Schneider SA; van de Warrenburg BP; Hughes TD; Davis M; Sweeney M; Wood N; Quinn NP; Bhatia KP
Neurology; 2006 Nov; 67(9):1701-3. PubMed ID: 17101913
[TBL] [Abstract][Full Text] [Related]
19. Repeat expansion in spinocerebellar ataxia type 17 alleles of the TATA-box binding protein gene: an evolutionary approach.
Tomiuk J; Bachmann L; Bauer C; Rolfs A; Schöls L; Roos C; Zischler H; Schuler MM; Bruntner S; Riess O; Bauer P
Eur J Hum Genet; 2007 Jan; 15(1):81-7. PubMed ID: 17033685
[TBL] [Abstract][Full Text] [Related]
20. TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease.
Reid SJ; van Roon-Mom WM; Wood PC; Rees MI; Owen MJ; Faull RL; Dragunow M; Snell RG
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):120-8. PubMed ID: 15193429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
